199 related articles for article (PubMed ID: 29805619)
41. Expression and clinical significance of the phosphatidylinositol 3-kinase/protein kinase B signal transduction pathway in non-small cell lung carcinoma.
Jiang AG; Yu H; Huang JA
Oncol Lett; 2014 Aug; 8(2):601-607. PubMed ID: 25013474
[TBL] [Abstract][Full Text] [Related]
42. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
[TBL] [Abstract][Full Text] [Related]
43. Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer.
Kong PZ; Li GM; Tian Y; Song B; Shi R
Oncotarget; 2016 Aug; 7(34):55601-55610. PubMed ID: 27487137
[TBL] [Abstract][Full Text] [Related]
44. Development of a Survival Prognostic Model for Non-small Cell Lung Cancer.
Zhang YH; Lu Y; Lu H; Zhou YM
Front Oncol; 2020; 10():362. PubMed ID: 32266143
[TBL] [Abstract][Full Text] [Related]
45. CD117 expression is a predictive marker for poor prognosis in patients with non-small cell lung cancer.
Sakabe T; Azumi J; Haruki T; Umekita Y; Nakamura H; Shiota G
Oncol Lett; 2017 May; 13(5):3703-3708. PubMed ID: 28521472
[TBL] [Abstract][Full Text] [Related]
46. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
Qu CH; Sun QY; Zhang FM; Jia YM
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
[TBL] [Abstract][Full Text] [Related]
47. Testes-specific protease 50 promotes cell proliferation via inhibiting activin signaling.
Song ZB; Wu P; Ni JS; Liu T; Fan C; Bao YL; Wu Y; Sun LG; Yu CL; Huang YX; Li YX
Oncogene; 2017 Oct; 36(43):5948-5957. PubMed ID: 28650473
[TBL] [Abstract][Full Text] [Related]
48. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
[TBL] [Abstract][Full Text] [Related]
49. Down-regulation of testes-specific protease 50 induces apoptosis in human laryngocarcinoma HEp2 cells in a NF-κB-mediated pathway.
Liu YL; Sun YN
Mol Biol Rep; 2014 Dec; 41(12):7743-7. PubMed ID: 25399078
[TBL] [Abstract][Full Text] [Related]
50. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
Chen SW; Wang TB; Tian YH; Zheng YG
Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
[TBL] [Abstract][Full Text] [Related]
51. Prognostic and diagnostic significance of long non-coding RNA AGAP2-AS1 levels in patients with non-small cell lung cancer.
Fan KJ; Liu Y; Yang B; Tian XD; Li CR; Wang B
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2392-2396. PubMed ID: 28617550
[TBL] [Abstract][Full Text] [Related]
52. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
53. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
[TBL] [Abstract][Full Text] [Related]
54. Cardamonin inhibited cell viability and tumorigenesis partially through blockade of testes-specific protease 50-mediated nuclear factor-kappaB signaling pathway activation.
Mi XG; Song ZB; Sun LG; Bao YL; Yu CL; Wu Y; Li YX
Int J Biochem Cell Biol; 2016 Apr; 73():63-71. PubMed ID: 26855338
[TBL] [Abstract][Full Text] [Related]
55. Notch-regulated ankyrin-repeat protein is a novel tissue biomarker that predicts poor prognosis in non-small cell lung cancer.
Liao Y; Chen J; Ma J; Mao Q; Wei R; Zheng J
Oncol Lett; 2018 Aug; 16(2):1885-1891. PubMed ID: 30008880
[TBL] [Abstract][Full Text] [Related]
56. Raf1 is a prognostic factor for progression in patients with non‑small cell lung cancer after radiotherapy.
Tian H; Yin L; Ding K; Xia YY; Wang XH; Wu JZ; He X
Oncol Rep; 2018 Apr; 39(4):1966-1974. PubMed ID: 29484414
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 in early stage of non-small cell lung cancer.
Lafuente-Sanchis A; Zúñiga Á; Galbis JM; Cremades A; Estors M; Martínez-Hernández NJ; Carretero J
Clin Transl Oncol; 2016 Aug; 18(8):798-804. PubMed ID: 26542178
[TBL] [Abstract][Full Text] [Related]
58. Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer.
Cheng YL; Lee SC; Harn HJ; Chen CJ; Chang YC; Chen JC; Yu CP
Eur J Cardiothorac Surg; 2003 Feb; 23(2):221-8. PubMed ID: 12559346
[TBL] [Abstract][Full Text] [Related]
59. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
[TBL] [Abstract][Full Text] [Related]
60. Correlation between microRNA expression, clinicopathological characteristics, and prognosis in patients with Non-small cell Lung Cancer: A retrospective study.
Wang X; Zhang Y; Zhi X
Thorac Cancer; 2017 Sep; 8(5):511-516. PubMed ID: 28727276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
